10x Genomics, Inc. TXG Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s operating lease ROU assets?
- 10x Genomics, Inc. (TXG) reported operating lease ROU assets of $58.39M in Q1 2026.
- How has 10x Genomics, Inc.'s operating lease ROU assets changed year-over-year?
- 10x Genomics, Inc.'s operating lease ROU assets increased by 5.1% year-over-year, from $55.58M to $58.39M.
- What is the long-term trend for 10x Genomics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease ROU assets has grown at a 5.2% compound annual growth rate (CAGR), from $46.98M to $60.45M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.